Analysis of Antibody Neutralisation Activity against SARS-CoV-2 Variants and Seasonal Human Coronaviruses NL63, HKU1, and 229E Induced by Three Different COVID-19 Vaccine Platforms (2022)
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.3390/vaccines11010058
Publication URI: http://dx.doi.org/10.3390/vaccines11010058
Type: Journal Article/Review
Parent Publication: Vaccines
Issue: 1